| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | Ho Carole73 | Chief Medical Officer | Sell | 7,092 | $66.38 | $470,740.97 | -0.6% | |
| Mar 1, 2021 | Tessier-Lavigne Marc69 | Director | Sell | 100,000 | $66.22 | $6,622,207.14 | -0.5% | |
| Mar 1, 2021 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $66.35 | $1,216,550.93 | -0.1% | |
| Feb 16, 2021 | Krognes Steve E.74 | CFO And Treasurer | Sell | 50,000 | $65.09 | $3,254,710.04 | -1.4% | |
| Feb 12, 2021 | Bratton Douglas K | 10% Owner | Sell | 2,216,798 | $65.00 | $144,091,870.00 | -18.2% | |
| Feb 11, 2021 | Ho Carole73 | Chief Medical Officer | Sell | 3,156 | $70.33 | $221,971.90 | -0.9% | |
| Feb 11, 2021 | Watts Ryan J.77 | President And CEO | Sell | 9,473 | $70.30 | $665,984.48 | -0.2% | |
| Feb 11, 2021 | Schuth Alexander O.75 | COO And Secretary | Sell | 3,047 | $70.35 | $214,341.43 | -0.3% | |
| Feb 11, 2021 | Krognes Steve E.74 | CFO And Treasurer | Sell | 3,035 | $70.34 | $213,479.69 | -1.5% | |
| Feb 9, 2021 | Watts Ryan J.77 | President And CEO | Sale+OE | 5,112 | $73.79 | $377,211.14 | - |